About Biolife
Biolife, L.L.C. is a privately owned company, founded in 1999 by Jim Reding, Charlie
Entenmann, John “Alf” Thompson and James Patterson, Ph.D and is headquartered in
Sarasota, Florida. In 2005, Biolife was recognized as the Florida Entrepreneurial Company
of the Year.
Biolife’s Vision, Mission and Values
Biolife’s vision is to contribute to the universal greater good by providing products that save
lives and reduce pain and suffering.
Biolife’s mission is to develop and market products that improve our consumer’s
quality of life.
Biolife’s values guide the company in fulfilling its mission. Each member of the Biolife family
strives to:
• Maintain a focus on the ever-changing needs of our current and potential customers
• Rely on data to continuously analyze and actively improve all of our processes
• Respect one another while recognizing each other’s intrinsic dignity and individuality
• Foster the discipline to plan effectively, communicate openly and work together
• Enjoy ourselves as we mature and develop as a company.
The Technology
Biolife has patented a breakthrough topical powder that forms a seal over a bleeding wound
or an access site. The powder stops bleeding and allows "nothing in and nothing out" of a
wound.
The original technology was developed in a lab by Thompson and Patterson by accident. They
were testing the potassium iron oxyacid salt for other purposes when Patterson cut his hand
and the powder came into contact with the cut. He was on blood thinners and the cut was
fairly deep, so he figured a trip to the emergency room was inevitable. Patterson was shocked
when the powder mixed with the blood and formed an instant scab that stopped the bleeding.
All that was known at the time was that the powder stopped bleeding very quickly regardless
of one’s ability to clot naturally.
That discovery was just the beginning. Since then, Biolife, L.L.C. has taken the product from
conception to commercialization and continues to test the product to develop new and
improved applications. Biolife has produced and sold over 5 million applications of the
technology to leading hospitals, occupational workplaces, professional sports teams and
consumers across the country.
Advisory Boards
Biolife has advisory boards for each key business segment. These groups provide insights
and objective feedback that guide our product development and commercialization.
Regulatory Status
Biolife has FDA (510k) clearance to market our products in the U.S. The products have
passed all required safety, toxicity and biocompatibility testing. As new healthcare indications
emerge, we are preparing and submitting additional 510k filings as required. For more
information on our regulatory status, please contact us at customer.care@biolife.com
Patents
The patent for the technology was filed on February 9, 2000. The patent number is
6,187,347. Other US and International Patents Pending.
Biolife, L.L.C. is a privately owned company, founded in 1999 by Jim Reding, Charlie
Entenmann, John “Alf” Thompson and James Patterson, Ph.D and is headquartered in
Sarasota, Florida. In 2005, Biolife was recognized as the Florida Entrepreneurial Company
of the Year.
Biolife’s Vision, Mission and Values
Biolife’s vision is to contribute to the universal greater good by providing products that save
lives and reduce pain and suffering.
Biolife’s mission is to develop and market products that improve our consumer’s
quality of life.
Biolife’s values guide the company in fulfilling its mission. Each member of the Biolife family
strives to:
• Maintain a focus on the ever-changing needs of our current and potential customers
• Rely on data to continuously analyze and actively improve all of our processes
• Respect one another while recognizing each other’s intrinsic dignity and individuality
• Foster the discipline to plan effectively, communicate openly and work together
• Enjoy ourselves as we mature and develop as a company.
The Technology
Biolife has patented a breakthrough topical powder that forms a seal over a bleeding wound
or an access site. The powder stops bleeding and allows "nothing in and nothing out" of a
wound.
The original technology was developed in a lab by Thompson and Patterson by accident. They
were testing the potassium iron oxyacid salt for other purposes when Patterson cut his hand
and the powder came into contact with the cut. He was on blood thinners and the cut was
fairly deep, so he figured a trip to the emergency room was inevitable. Patterson was shocked
when the powder mixed with the blood and formed an instant scab that stopped the bleeding.
All that was known at the time was that the powder stopped bleeding very quickly regardless
of one’s ability to clot naturally.
That discovery was just the beginning. Since then, Biolife, L.L.C. has taken the product from
conception to commercialization and continues to test the product to develop new and
improved applications. Biolife has produced and sold over 5 million applications of the
technology to leading hospitals, occupational workplaces, professional sports teams and
consumers across the country.
Advisory Boards
Biolife has advisory boards for each key business segment. These groups provide insights
and objective feedback that guide our product development and commercialization.
Regulatory Status
Biolife has FDA (510k) clearance to market our products in the U.S. The products have
passed all required safety, toxicity and biocompatibility testing. As new healthcare indications
emerge, we are preparing and submitting additional 510k filings as required. For more
information on our regulatory status, please contact us at customer.care@biolife.com
Patents
The patent for the technology was filed on February 9, 2000. The patent number is
6,187,347. Other US and International Patents Pending.
 | |  | |  | |  | |  |
| ABOUT BIOLIFE |
| Charlie Entenmann |
| John "Alf" Thompson |
| The Late James Patterson "Doc" |
| Board of Directors Ed Bavaria – Chairman Charlie Entenmann Alf Thompson Bob Reding Joanne Reding Sam Shake |
| Management Team Sam Shake – President and CEO Tim Kelly - Executive Vice President Andrew McFall - Vice President of Marketing Chip Bettle - Director of R&D Michele Slingluff - Chief Financial Officer Duncan Finlay - Chief Medical Director Roger Thomas - Strategic Support Projects |
| © 2010 Biolife LLC. All rights reserved ► 941-360-1300 ► 800-722-7559 Toll Free ► Email US |
| Empowering The World With A Revolutionary Powder |